Inhibitor Therapeutics (INTI) Shares Outstanding (2012 - 2026)
Inhibitor Therapeutics (INTI) recorded Shares Outstanding of 173.31 million in Q2 2026, up 0.4% from 172.57 million a year earlier and up 0.4% from the prior quarter.
Inhibitor Therapeutics (INTI) Shares Outstanding (2012 - 2026) Analysis & Trends
For FY2025, Inhibitor Therapeutics reported Shares Outstanding of 172.51 million, up 0.1% from FY2024.
- Annual Shares Outstanding has a five-year compound annual growth rate of -14.2% (FY2020 to FY2025).
- Across earlier years, Shares Outstanding came in at 172.26 million in FY2024 (+0.2%), 171.95 million in FY2023 (-53.0%), 366.18 million in FY2022 (-2.7%) and 376.25 million in FY2021 (+1.2%).
- The Q2 2026 figure is the highest quarterly Shares Outstanding since Q4 2022.
- On a year-over-year basis, Shares Outstanding has increased for ten consecutive quarters, with growth averaging 0.2% over the last eight quarters.
- Peak year-over-year performance for Shares Outstanding in the last five years was growth of 1.2% in Q4 2021, against a decline of 54.4% in Q1 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at 172.57 million (Q1 2026), 172.51 million (Q4 2025) and 172.57 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 891.90 Mn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 2.41 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 1.77 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 2.47 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 1.94 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 1.55 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 541.00 Mn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 1.24 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 5.70 Bn |
| 10 | Inhibitor Therapeutics | 13.90 Mn | 6.72 Mn | - | 173.31 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 173.31 Mn |
| Mar 31, 2026 | 172.57 Mn |
| Dec 31, 2025 | 172.51 Mn |
| Sep 30, 2025 | 172.57 Mn |
| Jun 30, 2025 | 172.57 Mn |
| Mar 31, 2025 | 172.32 Mn |
| Dec 31, 2024 | 172.26 Mn |
| Sep 30, 2024 | 172.32 Mn |
| Jun 30, 2024 | 172.32 Mn |
| Mar 31, 2024 | 172.08 Mn |
| Dec 31, 2023 | 171.95 Mn |
| Sep 30, 2023 | 172.01 Mn |
| Jun 30, 2023 | 171.97 Mn |
| Mar 31, 2023 | 171.79 Mn |
| Dec 31, 2022 | 366.18 Mn |
| Sep 30, 2022 | 376.86 Mn |
| Jun 30, 2022 | 376.86 Mn |
| Mar 31, 2022 | 376.86 Mn |
| Dec 31, 2021 | 376.25 Mn |
| Sep 30, 2021 | 376.71 Mn |
Inhibitor Therapeutics Shares Outstanding API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding&ticker=INTI&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding", "ticker": "INTI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding&ticker=INTI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();